Plaque formation often begins in the lower extremities.

GuideAI Health partners with preventive cardiology and executive health programmes to better analyse and interpret imaging data for peripheral arterial disease — which is often missed, and under-diagnosed.

Talk to our clinical team See what the programme returns →

GuideAI Health 3D vascular map — illustrative

The proposition

We don’t estimate the arterial tree. We characterise it.

Risk calculators infer. Imaging observes. Where a programme is already acquiring cross-sectional imaging, the arterial tree is visible — and can be read the way a vascular specialist would read it, segment by segment.

01 PAD and cardiovascular risk Peripheral arterial disease is one of the most under-recognised markers of systemic atherosclerosis, and is associated with a multifold higher risk of adverse cardiac events. In an executive population it is frequently present, frequently asymptomatic, and frequently never looked for.

02 GuideAI Health’s AI — analysis Every artery segment from the mid-abdomen to the ankle is identified, labelled and assessed. The output is a structured map — not a paragraph of impression — so the same anatomy can be compared to itself a year later.

03 Personalised therapy Plaque is not uniform. Calcified, soft and mixed morphology carry different implications, and that distinction is what turns a finding into a therapeutic decision — and into a metric to re-assess as plaque regression is monitored.

Scope of clearance. VascularAssist™ Occlusion Triage is FDA 510(k) cleared for triage and notification of suspected peripheral arterial occlusion. Quantified stenosis, plaque burden, plaque composition and longitudinal monitoring described on this page are investigational, are not cleared by the FDA, and are offered for research and programme-development use only.

What comes back

One scan. Detailed characterisation of the entire arterial tree.

A labelled stenosis map from the mid-abdomen to the ankle, precisely quantified stenosis and plaque burden, and plaque composition.

Structured report · per-segment grading

Read like a specialist, written like a record.

The report names each segment and grades it, rather than compressing the study into a single impression. Segments the study does not cover are marked not assessed — never inferred, never quietly graded.

Because the structure is identical every time, the next study is directly comparable to this one. That is the point of the programme: not a single verdict, but a baseline that can be moved.

Coverage	Mid-abdomen to ankle, segment by segment
Stenosis	Quantified per segment, with a consistent grading scale
Composition	Calcified and non-calcified burden, characterised per segment
Comparability	Identical structure study to study, for year-over-year re-assessment

What the analysis looks like

Arterial segmentation across the lower extremity

Illustrative screen capture of the GuideAI Health viewer. Segment-level stenosis quantification and plaque characterisation shown here are investigational, are not cleared by the FDA, and are outside the VascularAssist™ Occlusion Triage clearance for triage and notification.

The report on screen

Patient-level summary and landmark-level analysis

For the practice

It fits inside the physical you already run.

No new acquisition

Where the programme already acquires cross-sectional imaging that includes the abdomen and lower extremities, the analysis runs on that study. No additional visit, no additional scan, no additional contrast decision.

A finding you can act on

Morphology and burden give the physician something to prescribe against and something to measure. The conversation moves from a percentage risk to a specific artery.

A reason to come back

A structured baseline makes the annual return visit substantive. The patient is not re-hearing an estimate — they are seeing whether the thing that was there last year is still there.

One scan. The whole arterial tree — characterised, not summarised.

The executive health programme

Getting started

Four conversations, not a procurement cycle.

01 Imaging review We look at the studies your programme already acquires and confirm which of them carry the anatomy this analysis needs. Week 1

02 Retrospective read A structured read of de-identified prior studies, so your physicians see the output on their own patients before anything changes. Weeks 2–4

03 Report design We adapt the structured report to how your programme presents findings to patients, including practice branding where appropriate. Weeks 4–6

04 Programme launch Live within the executive physical, with a defined baseline and an agreed cadence for re-assessment. Week 8

Bring it into your executive physical.

We will run a structured retrospective read on your own de-identified studies before either of us commits to anything.

Talk to our clinical team See the platform